Your Health Plan:
Your Health Plan:
Not SelectedIMBRUVICA (ibrutinib) is a brand-name prescription drug for treatment of Bronchiolitis Obliterans Syndrome. IMBRUVICA is a kinase inhibitor. It is available in the form of oral capsule / oral tablet / oral suspension.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $10800-26400.
Patient Assistance Prorgams and Coupons are found:
No other option is found for IMBRUVICA